Emcure Pharmaceuticals Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 1,475.96 | 1,502.22 | 1,556.61 |
| Operating Expense | 1,111.35 | 1,096.05 | 1,146.95 |
| Net Profit | 200.11 | 233.70 | 258.85 |
| Net Profit Margin | 13.56% | 15.56% | 16.63% |
| Earning Per Share | 10.55 | 12.33 | 13.65 |
| EBIDTA | 366.41 | 412.47 | 419.03 |
| Effective Tax Rate | 19.29% | 19.42% | 15.84% |
Particulars
Jun 2026
Revenue1,475.96
Operating Expense1,111.35
Net Profit200.11
Net Profit Margin13.56
Earning Per Share10.55
EBIDTA366.41
Effective Tax Rate19.29
